Investors Home

Company Profile

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney disease and acute ischemic stroke. DiaMedica's shares are listed on The Nasdaq Capital Market under the trading symbol "DMAC."

-

Nasdaq Stock Snapshot

DMAC Symbol
Nasdaq Market
-- Volume
-- Price
-- Change
Go to Detailed Stock Information ›

Upcoming Events

Third Quarter 2019 Financial Results Conference Call

Dial In:
(844) 557-8483 (domestic)
(825) 312-2381 (international)

Conference ID: 4594493

Listeners should log on to the website or dial in 15 minutes prior to the call. 

A telephonic replay of the conference call will be available until November 21, 2019, by dialing (800) 585-8367 (US Toll Free), (416) 621-4642 (International), replay passcode 4594493.

View Events ›